Targeting inflammatory pathway reduces Alzheimer's disease in mice

December 15, 2014, Journal of Clinical Investigation

Alzheimer's disease (AD) is the most common form of dementia and is characterized by the formation of β-amyloid plaques throughout the brain. Proteins known as chemokines regulate inflammation and the immune response. In both patients with AD and mouse AD models, the chemokine CXCL10 is found in high concentrations in the brain and may contribute to AD.

A new study in the Journal of Clinical Investigation indicates that activation of the CXCL10 receptor, CXCR3, contributes to AD pathology. Using a murine model of AD, Michael Heneka and colleagues at the University of Bonn found that mice lacking CXCR3 had reduced β-amyloid plaque formation. Importantly, loss of CXCR3 signaling in AD mice attenuated .

The results of this study suggest that CXCR3 should be explored as a potential therapeutic target for AD.

Explore further: Inflammatory mediator enhances plaque formation in Alzheimer's disease

More information: CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer's disease model, J Clin Invest. DOI: 10.1172/JCI66771

Related Stories

Inflammatory mediator enhances plaque formation in Alzheimer's disease

September 7, 2011
Alzheimer's disease (AD) is a devastating neurodegenerative disorder that causes progressive cognitive impairment and memory loss. Now, a new study published by Cell Press in the September 8 issue of the journal Neuron identifies ...

Drugs targeting blood vessels may be candidates for treating Alzheimer's

March 7, 2013
(Medical Xpress)—University of British Columbia researchers have successfully normalized the production of blood vessels in the brain of mice with Alzheimer's disease (AD) by immunizing them with amyloid beta, a protein ...

Study examines association between small-vessel disease, Alzheimer pathology

May 12, 2014
Cerebral small-vessel disease (SVD) and Alzheimer disease (AD) pathology appear to be associated.

Bilingualism delays Alzheimer manifestation by more than four years

December 1, 2014
A new study at Ghent University has established that the symptoms of Alzheimer disease (AD) manifest themselves about four to five years later in bilinguals as opposed to monolinguals. In bilinguals, the disease onset was ...

'Alzheimer's in a Dish' model induces skin cells into neurons expressing amyloid-beta (w/ Video)

December 5, 2014
The search for a living laboratory model of human neurons in the grip of Alzheimer's disease (AD)—the so-called "Alzheimer's in a dish"—has a new candidate. In work presented at the ASCB/IFCB meeting in Philadelphia, ...

Study links enzyme to Alzheimer's disease

July 21, 2014
Unclogging the body's protein disposal system may improve memory in patients with Alzheimer's disease (AD), according to a study from scientists at Kyungpook National University in Korea published in The Journal of Experimental ...

Recommended for you

Exercise may delay cognitive decline in people with rare Alzheimer's disease

September 25, 2018
For individuals carrying a genetic mutation that causes Alzheimer's disease, engaging in at least 2.5 hours of physical activity per week may have beneficial effects on markers of Alzheimer's disease brain changes and may ...

Scientists reveal ground-breaking plan to target cause of Alzheimer's disease

September 24, 2018
A breakthrough has been made in the fight against Alzheimer's disease—researchers have found a new way to target the toxic particles that destroy healthy brain cells.

A biomarker in the brain's circulation system may be Alzheimer's earliest warning

September 24, 2018
USC scientists say Alzheimer's could be diagnosed earlier if scientists focus on an early warning within the brain's circulation system.

In landmark study, doctors say test identifies people most likely to get Alzheimer's

September 24, 2018
The beginning was the worst. It frustrated Janet Parkerson when her father started to forget what he had done that day or the day before.

Study clarifies ApoE4's role in dementia

September 20, 2018
ApoE4, a protein linked to both Alzheimer's disease and a form of dementia caused by damage of blood vessels in the brain, increases the risk of cognitive impairment by reducing the number and responsiveness of blood vessels ...

Machine learning IDs markers to help predict Alzheimer's

September 19, 2018
Nearly 50 million people worldwide have Alzheimer's disease or another form of dementia. These irreversible brain disorders slowly cause memory loss and destroy thinking skills, eventually to such an extent that self-care ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.